申请人:AUTOPHAGYSCIENCES INC.
公开号:US20210078987A1
公开(公告)日:2021-03-18
The present disclosure relates to a novel compound and a pharmaceutical composition comprising the same. The compound according to the present disclosure has effects for activating autophagy, and thus can be valuably used for preventing or treating diseases associated with autophagy regulation.
本公开涉及一种新化合物和包含该化合物的药物组合物。根据本公开的化合物具有激活自噬的效果,因此可以用于预防或治疗与自噬调节相关的疾病。